Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT ...

Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a ...

18 F-FDG-PET/CT (F-FDG) appears to offer value for staging of cutaneous squamous cell carcinoma (cSCC), according to the results of a recent small, single-institution study. 1 F-FDG reliably detected ...

The Journal of Clinical Oncology has published the results of the largest prospective multicenter trial conducted of FDG-PET/CT in head and neck cancer, providing rigorous data about its performance.

Staging locally advanced breast cancer patients with 18 F-labeled fluorodeoxyglucose (FDG) PET-CT detected more distant metastases -- and thus reduced the number of patients who received combined ...

FDG-PET/CT could be very helpful in calculating the risk of developing interval metastasis during neoadjuvant chemoradiotherapy for oesophageal cancer, and it could lead to other more appropriate ...

Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial ...

A new Journal of Clinical Oncology report immediately informs practicing clinicians of the effectiveness and benefits of FDG-PET/CT in head and neck cancer patients, especially those who are ...